Gilead Sciences Inc
23 bondsCorporates๐บ๐ธ US
About Gilead Sciences Inc
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Gilead is a member of the Nasdaq-100 and the S&P 100.
SOURCE: WIKIPEDIA โMaturity ladder
Active bonds by year of maturity
20274
20292
20302
20332
20352
20361
20401
20411
20441
20451
20461
20471
20501
20531
20541
20641
Currency mix
USD23 ยท 100%
Issuing countries
Ratings
S&P
A-
Moody's
A3
5 of 23 bonds rated